IRWD
Price:
$4.59
Market Cap:
$734.53M
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary ch...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-02-03
Stock Exchange
NASDAQ
Ticker
IRWD
According to Ironwood Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -459.00. This represents a change of 132.95% compared to the average of -197.04 of the last 4 quarters.
The mean historical PE Ratio of Ironwood Pharmaceuticals, Inc. over the last ten years is -18.01. The current -459.00 PE Ratio has changed 254.73% with respect to the historical average. Over the past ten years (40 quarters), IRWD's PE Ratio was at its highest in in the March 2020 quarter at 119.43. The PE Ratio was at its lowest in in the December 2023 quarter at -410.49.
Average
-18.01
Median
-8.33
Minimum
-135.61
Maximum
17.10
Discovering the peaks and valleys of Ironwood Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.32%
Maximum Annual PE Ratio = 17.10
Minimum Annual Increase = -116.24%
Minimum Annual PE Ratio = -135.61
Year | PE Ratio | Change |
---|---|---|
2023 | -1.77 | -116.24% |
2022 | 10.93 | 205.18% |
2021 | 3.58 | -79.07% |
2020 | 17.10 | -112.61% |
2019 | -135.61 | 2.32% |
2018 | -5.60 | -70.57% |
2017 | -19.03 | -29.85% |
2016 | -27.12 | 134.84% |
2015 | -11.55 | 4.48% |
2014 | -11.05 | 124.20% |
The current PE Ratio of Ironwood Pharmaceuticals, Inc. (IRWD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.24
5-year avg
-21.15
10-year avg
-18.01
Ironwood Pharmaceuticals, Inc.’s PE Ratio is less than Neurocrine Biosciences, Inc. (35.89), less than Amphastar Pharmaceuticals, Inc. (12.06), less than Collegium Pharmaceutical, Inc. (10.61), less than ANI Pharmaceuticals, Inc. (-148.34), less than Alkermes plc (14.46), less than Intra-Cellular Therapies, Inc. (-102.87), less than Deciphera Pharmaceuticals, Inc. (-11.74), less than Pacira BioSciences, Inc. (-9.76), less than Avadel Pharmaceuticals plc (-13.45), less than Eagle Pharmaceuticals, Inc. (0.20), less than Assertio Holdings, Inc. (-1.18), less than Esperion Therapeutics, Inc. (-5.03),
Company | PE Ratio | Market cap |
---|---|---|
35.89 | $13.87B | |
12.06 | $1.88B | |
10.61 | $940.09M | |
-148.34 | $1.14B | |
14.46 | $4.77B | |
-102.87 | $8.91B | |
-11.74 | $2.21B | |
-9.76 | $886.53M | |
-13.45 | $977.11M | |
0.20 | $7.13M | |
-1.18 | $80.77M | |
-5.03 | $441.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ironwood Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ironwood Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ironwood Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Ironwood Pharmaceuticals, Inc. (IRWD)?
What is the highest PE Ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?
What is the 3-year average PE Ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?
What is the 5-year average PE Ratio for Ironwood Pharmaceuticals, Inc. (IRWD)?
How does the current PE Ratio for Ironwood Pharmaceuticals, Inc. (IRWD) compare to its historical average?